Case Study: CyPath® Lung Detects Stage 1A Lung Cancer in High-Risk Patient with Inconclusive Imaging; bioAffinity Technologies' noninvasive sputum test revealed early-stage lung cancer when other diagnostic options were contraindicated

Press/Media

Period9 Jul 2025 → 10 Jul 2025

Media coverage

9

Media coverage